A Comparative Study of Flash Nanoprecipitation and Sequential Nanoprecipitation: Impact of Formulation Parameters on Drug-Loaded Nanoparticle Formation
Molecular Pharmaceutics · 06.10.2025 · 22 (10) · 6108-6119
DOI: 10.1021/acs.molpharmaceut.5c00835 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Molecular Pharmaceutics, online erschienen am 17.09.2025. Verfasst von Nouha El Amri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn, New York 11201, United States. Hauptthemen laut MEDLINE: Chemical Precipitation, Nanoparticles, Nanocapsules. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, New York University.
Abstract (Originalsprache)
Flash NanoPrecipitation (FNP) is a well-established method for forming core-shell drug-loaded nanoparticles that has demonstrated effectiveness for encapsulating highly hydrophobic compounds. However, certain formulation challenges persist, including size limitations and reduced encapsulation efficiency for moderately hydrophobic drugs. Sequential NanoPrecipitation (SNaP) is a novel nanoparticle synthesis process that relies on the same assembly principle as FNP, while decoupling the core formation and stabilization. Through a systematic comparison using drugs with varying hydrophobicity, we demonstrate complementary capabilities between these techniques. We showed that for the high hydrophobicity drugs such as β-carotene, both SNaP and FNP performed effectively. In the case of cinnarizine, a moderately hydrophobic drug that requires the use of hydrophobic ion pairing, good encapsulation efficiency was observed for the case of SNaP, while no encapsulation was observed with FNP. For ibuprofen, a water-soluble analgesic, low encapsulation efficiency was observed with SNaP, and no loading was observed with FNP. Release studies with itraconazole nanoparticles revealed that SNaP-produced nanoparticles exhibited approximately 50% slower release rates compared to FNP over 48 h. Additionally, SNaP enabled access to a broader size range and successful nanoparticle formation at lower solid concentrations. These findings establish SNaP as a valuable complement to FNP, particularly for applications requiring larger nanoparticles, encapsulation of moderately hydrophobic compounds, or modified release kinetics. Together, these nanoprecipitation approaches provide formulators with expanded capabilities for developing polymeric nanoparticle drug delivery systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Tandon School of Engineering, New York University, Brooklyn, New York 11201, United States.
- Department of Biomedical Engineering, Tandon School of Engineering, New York University, Brooklyn, New York 11201, United States.
ORCID-Profile: Nathalie M Pinkerton
Förderung
- NCI NIH HHS
- New York University
Zitieren
APA
El Amri, N., McKinstry, A. H., Pollard, R. E., Lewis, P. K., & Pinkerton, N. M. (2025). A Comparative Study of Flash Nanoprecipitation and Sequential Nanoprecipitation: Impact of Formulation Parameters on Drug-Loaded Nanoparticle Formation. Molecular Pharmaceutics, 22(10), 6108-6119. https://doi.org/10.1021/acs.molpharmaceut.5c00835
Vancouver
El Amri N, McKinstry AH, Pollard RE, Lewis PK, Pinkerton NM. A Comparative Study of Flash Nanoprecipitation and Sequential Nanoprecipitation: Impact of Formulation Parameters on Drug-Loaded Nanoparticle Formation. Molecular Pharmaceutics. 2025;22(10):6108-6119. doi:10.1021/acs.molpharmaceut.5c00835
BibTeX
@article{ElAmri2025,
author = {El Amri, Nouha and McKinstry, Amy H and Pollard, Rachel E and Lewis, Parker K and Pinkerton, Nathalie M},
title = {A Comparative Study of Flash Nanoprecipitation and Sequential Nanoprecipitation: Impact of Formulation Parameters on Drug-Loaded Nanoparticle Formation},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {10},
pages = {6108--6119},
doi = {10.1021/acs.molpharmaceut.5c00835}
}
EUVIMED